High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Jun 2022	51	Global Markets Direct	ASDR-607653

Published: Jun 2022 - Pages : 51 - Publisher : Global Markets Direct - Report code : ASDR-607653

180 Life Sciences Corp
Chimerix Inc
KaliVir Immunotherapeutics Inc
Shionogi & Co Ltd
TheraSource LLC